References
- Aggarwal, B. B., A. Kumar, and A. C. Bharti. 2003. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Research 23 (1A): 363–98.
- Asfour, M. H., and A. M. Mohsen. 2018. Formulation and evaluation of pH-sensitive rutin nanospheres against colon carcinoma using HCT-116 cell line. Journal of Advanced Research 9:17–26. doi:https://doi.org/10.1016/j.jare.2017.10.003.
- Baka, E., J. E. A. Comer, and K. Takács-Novák. 2008. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. Journal of Pharmaceutical and Biomedical Analysis 46 (2):335–41. doi:https://doi.org/10.1016/j.jpba.2007.10.030.
- Baliga, M. S., N. Joseph, M. V. Venkataranganna, and A. Saxena, V. Ponemone, and R. Fayad. 2012. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations. Food and Function 3:1109–17. doi:https://doi.org/10.1039/c2fo30097d.
- Banerjee, R., A. Penmetsa, K. Medaboina, G. G. Boramma, S. Amsrala, and D. N. Reddy. 2017. Novel bio-enhanced curcumin with mesalamine for induction of remission in mild to moderate ulcerative colitis. Gastroenterology 152 (5):S587. doi:https://doi.org/10.1016/s0016-5085.(17)32111-x.
- Bisht, S., G. Feldmann, S. Soni, R. Ravi, C. Karikar, A. Maitra, and A. Maitra. 2007. Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): A novel strategy for human cancer therapy. Journal of Nanobiotechnology 5 (1):3. doi:https://doi.org/10.1186/1477-3155-5-3.
- Blanqué, D., H. Sternagel, F. Podczeck, and J. M. Newton. 1995. Some factors influencing the formation and in vitro drug release from matrix pellets prepared by extrusion/spheronization. International Journal of Pharmaceutics 119 (2):203–11. doi:https://doi.org/10.1016/0378-5173.(94)00394-K.
- Chereddy, K. K., R. Coco, P. B. Memvanga, B. Ucakar, A. Des Rieux, G. Vandermeulen, and V. Préat. 2013. Combined effect of PLGA and curcumin on wound healing activity. Journal of Controlled Release 171 (2):208–15. doi:https://doi.org/10.1016/j.jconrel.2013.07.015.
- The European Agency for the Evaluation of Medicinal Products. 1993. ICH topic Q1 a stability testing guidelines: Stability testing of new drug substances and products. http://www.eudra.org/emea.html.
- Dengale, S. J., H. Grohganz, T. Rades, and K. Löbmann. 2016. Recent advances in co-amorphous drug formulations. Advanced Drug Delivery Reviews 100:116–25. doi:https://doi.org/10.1016/j.addr.2015.12.009.
- Einfal, T., O. Planinšek, and K. Hrovat. 2013. Methods of amorphization and investigation of the amorphous state. Acta Pharmaceutica 63 (3):305–34. doi:https://doi.org/10.2478/acph-2013-0026.
- El-Gazayerly, O. N. 2003. Release of pentoxifylline from xanthan gum matrix tablets. Drug Development and Industrial Pharmacy 29 (2):241–6. doi:https://doi.org/10.1081/ddc-120016732.
- Erkoboni, D. F. 2003. Extrusion/spheronization. In: Pharmaceutical Extrusion Technology :277–322. doi:https://doi.org/10.1201/9780203911532.ch15.
- Erkoboni, D. F. 2003. Extrusion/spheronization. In Pharmaceutical Extrusion Technology, ed. I. Ghebre-Sellassie and C. Martin, 277–322. New York: Marcel Dekker Inc.
- Gao, Y., J. Liao, X. Qi, and J. Zhang. 2013. Coamorphous repaglinide-saccharin with enhanced dissolution. International Journal of Pharmaceutics 450 (1–2):290–5. doi:https://doi.org/10.1016/j.ijpharm.2013.04.032.
- Goud, N. R., K. Suresh, P. Sanphui, and A. Nangia. 2012. Fast dissolving eutectic compositions of curcumin. International Journal of Pharmaceutics 439 (1–2):63–72. doi:https://doi.org/10.1016/j.ijpharm.2012.09.045.
- Gowda, D. V., N. Rajesh, A. Moin, and H. G. Shivakumar. 2010. Controlled release behaviour of nifedipine from the pellets of gelucire/microcrystalline cellulose blends. International Journal of PharmTech Research 2 (2):1215–26.
- Holt, P. R., S. Katz, and R. Kirshoff. 2005. Curcumin therapy in inflammatory bowel disease: A pilot study. Digestive Diseases and Sciences 50 (11):2191–3. doi:https://doi.org/10.1007/s10620-005-3032-8.
- Indira, K. I. P. 1997. Free radical reactions of curcumin in membrane models. Free Radical Biology and Medicine 23 (6):838–43. doi:https://doi.org/10.1016/S0891-5849.(97)00026-9.
- Jensen, K. T., K. Löbmann, T. Rades, and H. Grohganz. 2014. Improving co-amorphous drug formulations by the addition of the highly water soluble amino acid, proline. Pharmaceutics 6 (3):416–35. doi:https://doi.org/10.3390/pharmaceutics6030416.
- Jovanovic, S. V., C. W. Boone, S. Steenken, M. Trinoga, and R. B. Kaskey. 2001. How curcumin works preferentially with water soluble antioxidants. Journal of the American Chemical Society 123 (13):3064–8. doi:https://doi.org/10.1021/ja003823x.
- Jurenka, J. S. 2009. Anti-inflammatory properties of curcumin, a major constituent of curcuma longa: a review of preclinical and clinical research. Alternative Medicine Review 14 (2):141–53.
- Karade, P. G., and N. R. Jadhav. 2018. Colon targeted curcumin microspheres laden with ascorbic acid for bioavailability enhancement. Journal of Microencapsulation 35 (4):372–80. doi:https://doi.org/10.1080/02652048.2018.1501111.
- Kohli, K., J. Ali, M. J. Ansari, and Z. Raheman. 2005. Curcumin: A natural antiinflammatory agent. Indian Journal of Pharmacology 37 (3):141. doi:https://doi.org/10.4103/0253-7613.16209.
- Lang, A., N. Salomon, J. C. Y. Wu, U. Kopylov, A. Lahat, O. Har-Noy, J. Y. L. Ching, P. K. Cheong, B. Avidan, D. Gamus, et al. 2015. Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial. Clinical Gastroenterology and Hepatology 13 (8):1444–9. doi:https://doi.org/10.1016/j.cgh.2015.02.019.
- Lobmann, K., H. Grohganz, R. Laitinen, C. Strachan, and T. Rades. 2013. Amino acids as co-amorphous stabilizers for poorly water soluble drugs - part 1: Preparation, stability and dissolution enhancement. European Journal of Pharmaceutics and Biopharmaceutics 85 (3):873–81.
- Löbmann, K., R. Laitinen, H. Grohganz, K. C. Gordon, C. Strachan, and T. Rades. 2011. Coamorphous drug systems: Enhanced physical stability and dissolution rate of indomethacin and naproxen. Molecular Pharmaceutics 8 (5):1919–28. doi:https://doi.org/10.1021/mp2002973.
- Löbmann, K., C. Strachan, H. Grohganz, T. Rades, O. Korhonen, and R. Laitinen. 2012. Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions. European Journal of Pharmaceutics and Biopharmaceutics 81 (1):159–69. doi:https://doi.org/10.1016/j.ejpb.2012.02.004.
- Madgulkar, A. R., M. R. Bhalekar, and R. R. Padalkar. 2009. Formulation design and optimization of novel taste masked mouth-dissolving tablets of tramadol having adequate mechanical strength. AAPS PharmSciTech 10 (2):574–81. doi:https://doi.org/10.1208/s12249-009-9237-y.
- Maher, E. M., A. M. A. Ali, H. F. Salem, and A. A. Abdelrahman. 2016. In vitro/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids. Drug Delivery 23 (8):3088–100. doi:https://doi.org/10.3109/10717544.2016.1153746.
- Masuda, T., Y. Yoshihashi, E. Yonemochi, K. Fujii, H. Uekusa, and K. Terada. 2012. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir. International Journal of Pharmaceutics 422 (1–2):160–9. doi:https://doi.org/10.1016/j.ijpharm.2011.10.046.
- Mehta, R., A. Chawla, P. Sharma, and P. Pawar. 2013. Formulation and in vitro evaluation of eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery system. Journal of Advanced Pharmaceutical Technology & Research 4 (1):31–41. doi:https://doi.org/10.4103/2231-4040.107498.
- Mohan, P., R, Krishna, G. Sreelakshmi, C. V. Muraleedharan, and R. Joseph. 2012. Water soluble complexes of curcumin with cyclodextrins: characterization by FT-Raman spectroscopy. Vibrational Spectroscopy 62:77–84. doi:https://doi.org/10.1016/j.vibspec.2012.05.002.
- Mughal, M. A., Z. Iqbal, and S. H. Neau. 2011. Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride. AAPS PharmSciTech 12 (1):77–87. doi:https://doi.org/10.1208/s12249-010-9570-1.
- Nguyen, T. N. G., P. Ha Lien Tran, T. V. Vo, T. Van Tran, and T. T. D. Tran. 2015. Dissolution enhancement of curcumin by solid dispersion with polyethylene glycol 6000 and hydroxypropyl methylcellulose. IFMBE Proceedings 46:298–301. doi:https://doi.org/10.1007/978-3-319-11776-8_72.
- Oetari, S., M. Sudibyo, J. N. M. Commandeur, R. Samhoedi, and N. P. E. Vermeulen. 1996. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Biochemical Pharmacology 51 (1):39–45. doi:https://doi.org/10.1016/0006-2952(95)02113-2.
- Padayatty, S. J., A. Katz, Y. Wang, P. Eck, O. Kwon, J.-H. Lee, S. Chen, C. Corpe, A. Dutta, S. K. Dutta, et al. 2003. Vitamin C as an antioxidant: Evaluation of its role in disease prevention. Journal of the American College of Nutrition 22 (1):18–35. doi:https://doi.org/10.1080/07315724.2003.10719272.
- Pandey, S., S. M. Vijayendra Swamy, A. Gupta, A. Koli, S. Patel, F. Maulvi, and B. Vyas. 2018. Multiple response optimisation of processing and formulation parameters of pH sensitive sustained release pellets of capecitabine for targeting colon. Journal of Microencapsulation 35 (3):259–71. doi:https://doi.org/10.1080/02652048.2018.1465138.
- Qian, S., W. Heng, Y. Wei, J. Zhang, and Y. Gao. 2015. Coamorphous lurasidone hydrochloride-saccharin with charge-assisted hydrogen bonding interaction shows improved physical stability and enhanced dissolution with Ph-independent solubility behavior. Crystal Growth and Design 15 (6):2920–8. doi:https://doi.org/10.1021/acs.cgd.5b00349.
- Ravindranath, V., and N. Chandrasekhara. 1980. Absorption and tissue distribution of curcumin in rats. Toxicology 16 (3):259–65. doi:https://doi.org/10.1016/0300-483X(80)90122-5.
- Roy, S. D., and G. L. Flynn. 1989. Solubility behavior of narcotic analgesics in aqueous media: Solubilities and dissociation constants of morphine, fentanyl, and sufentanil. Pharmaceutical Research 06 (2):147–51. doi:https://doi.org/10.1023/A:1015932610010..
- Sadeghi, F., M. Ashofteh, A. Homayouni, M. Abbaspour, A. Nokhodchi, and H. A. Garekani. 2016. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement. Colloids and Surfaces. B, Biointerfaces 147:258–64. doi:https://doi.org/10.1016/j.colsurfb.2016.08.004.
- Shoghi, E., E. Fuguet, E. Bosch, and C. Ràfols. 2013. Solubility-pH profiles of some acidic, basic and amphoteric drugs. European Journal of Pharmaceutical Sciences 48 (1–2):291–300. doi:https://doi.org/10.1016/j.ejps.2012.10.028.
- Singh, R., S. S. Poddar, and A. Chivate. 2007. Sintering of wax for controlling release from pellets. AAPS PharmSciTech 8 (3):E175–83. doi:https://doi.org/10.1208/pt0803074.
- Singla, V., V. Pratap Mouli, S. K. Garg, T. Rai, B. N. Choudhury, P. Verma, R. Deb, V. Tiwari, S. Rohatgi, R. Dhingra, et al. 2014. Induction with NCB-02 (Curcumin) enema for mild-to-moderate distal ulcerative colitis - A randomized, placebo-controlled, pilot study. Journal of Crohn’s and Colitis 8 (3):208–14. doi:https://doi.org/10.1016/j.crohns.2013.08.006.
- Skieneh, J. M., I. Sathisaran, S. V. Dalvi, and S. Rohani. 2017. Co-amorphous form of curcumin-folic acid dihydrate with increased dissolution rate. Crystal Growth and Design 17 (12):6273–80. doi:https://doi.org/10.1021/acs.cgd.7b00947.
- Sugimoto, K., H. Hanai, K. Tozawa, T. Aoshi, M. Uchijima, T. Nagata, and Y. Koide. 2002. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 123 (6):1912–22. doi:https://doi.org/10.1053/gast.2002.37050.
- Ting, Y., Y. Jiang, C. T. Ho, and Q. Huang. 2014. Common delivery systems for enhancing in vivo bioavailability and biological efficacy of nutraceuticals. Journal of Functional Foods 7 (1):112–28. doi:https://doi.org/10.1016/j.jff.2013.12.010.
- Villegas, I., S. Sánchez-Fidalgo, and C. A. D. L. Lastra. 2008. New mechanisms and therapeutic potential of curcumin for colorectal cancer. Molecular Nutrition and Food Research 52 (9): 1040–61. doi:https://doi.org/10.1002/mnfr.200700280..
- Wahlstrom, B., and G. Blennow. 1978. A study on the fate of curcumin in the rat. Acta Pharmacologica et Toxicologica 43 (2):86–92. doi:https://doi.org/10.1111/j.1600-0773.1978.tb02240.x.
- Wang, Y. J., M. H. Pan, A. L. Cheng, L. I. Lin, Y. S. Ho, C. Y. Hsieh, and J. K. Lin. 1997. Stability of curcumin in buffer solutions and characterization of its degradation products. Journal of Pharmaceutical and Biomedical Analysis 15 (12):1867–76. doi:https://doi.org/10.1016/S0731-7085. (96)02024-9.
- Yallapu, M. M., M. Jaggi, and S. C. Chauhan. 2010. Beta-cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids and Surfaces. B, Biointerfaces 79 (1):113–25. doi:https://doi.org/10.1016/j.colsurfb.2010.03.039.
- Zhang, C., D. M. Dabbs, L. Min Liu, I. A. Aksay, R. Car, and A. Selloni. 2015. Combined effects of functional groups, lattice defects, and edges in the infrared spectra of graphene oxide. The Journal of Physical Chemistry C 119 (32):18167–76. doi:https://doi.org/10.1021/acs.jpcc.5b02727.